JPRN-UMIN000046613尚未招募未知
Prospective randomized trial of angiotensin receptor neprilysin inhibitor addition after ablation for atrial fibrillation with hypertension - Prospective randomized trial of angiotensin receptor neprilysin inhibitor addition after ablation for atrial fibrillation with hypertension
Cardiology University Northern Yokohama Hospital0 个研究点目标入组 200 人开始时间: 2022年1月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are intolerant for ARNI Patients with renal insufficiency (estimated GFR < 30) Patients with systolic blood pressure <100 mmHg When the attending physician consider inappropriate to enroll the patient in the study
研究者
相似试验
已完成
不适用
Prevention of complications after endoscopic retrograde cholangio-pancreaticography using the antihypertensive drug Cozaar®Post-endoscopic retrograde cholangio-pancreaticography pancreatitisDigestive SystemAcute pancreatitisISRCTN61320108Karolinska Institutet (Sweden)80
进行中（未招募）
1 期
A randomised controlled trial of the angiotensin converting enzyme inhibitor ramipril in asymptomatic aortic stenosis - Ramipril in aortic stenosis (RIAS)EUCTR2007-005224-32-GBniversity of Oxford100
已完成
不适用
A randomised controlled trial of the angiotensin converting enzyme (ACE) inhibitor ramipril in asymptomatic aortic stenosisISRCTN24616095niversity of Oxford (UK)100
招募中
3 期
A randomized competitive trial of Angiotensin II Receptor Blocker (ARB) for prevention of tumor recurrence in non-muscle invasive bladder cancerBladder cancerJPRN-UMIN000005044Keio University Hospital200
已完成
不适用
A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with HypertensioAtrial Fibrillation with HypertensionJPRN-C000000427The J-RHYTHM II Investigators400